Financhill
Buy
66

CHGCF Quote, Financials, Valuation and Earnings

Last price:
$57.95
Seasonality move :
10.47%
Day range:
$55.85 - $57.95
52-week range:
$38.76 - $72.30
Dividend yield:
1.38%
P/E ratio:
32.91x
P/S ratio:
11.34x
P/B ratio:
7.38x
Volume:
1.8K
Avg. volume:
1.7K
1-year change:
27.76%
Market cap:
$95.4B
Revenue:
$8.4B
EPS (TTM):
$1.76

Earnings Data

Next earnings date for CHGCF
Apr 24
2026
Most recent earnings per share
$0.51
Beat by $0.51
(Jan 29/2026)
Consensus Estimate
--
(Jan 29/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHGCF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/29/2026 Q4 -- $2.2B $0.51 -- --
10/24/2025 Q3 -- $2.3B $0.46 -- --
06/30/2025 Q2 -- $2B $0.41 -- --
04/24/2025 Q1 -- $1.9B $0.39 -- --
12/31/2024 Q4 -- $2B $0.37 -- --
10/25/2024 Q3 -- $2.1B $0.45 -- --
07/25/2024 Q2 -- $2B $0.44 -- --
04/24/2024 Q1 -- $1.6B $0.30 -- --
02/01/2024 Q4 -- $1.9B $0.37 -- --
09/30/2023 Q3 -- $1.8B $0.33 -- --
07/27/2023 Q2 -- $1.9B $0.37 -- --
04/27/2023 Q1 -- $2.4B $0.34 -- --
12/31/2022 Q4 -- $3.1B $0.44 -- --
10/24/2022 Q3 -- $1.6B $0.30 -- --
07/21/2022 Q2 -- $1.8B $0.34 -- --
04/25/2022 Q1 -- $2.3B $0.69 -- --
02/03/2022 Q4 -- $2.8B $0.53 -- --
10/22/2021 Q3 -- $2.6B $0.47 -- --
07/26/2021 Q2 -- $2B $0.39 -- --
04/22/2021 Q1 -- $1.6B $0.27 -- --
02/04/2021 Q4 -- $2B $0.30 -- --
10/22/2020 Q3 -- $2B $0.34 -- --
07/27/2020 Q2 -- $1.8B $0.29 -- --
04/23/2020 Q1 -- $1.6B $0.29 -- --
01/30/2020 Q4 -- $1.6B $0.22 -- --
10/24/2019 Q3 -- $1.8B $0.27 -- --
07/25/2019 Q2 -- $1.5B $0.19 -- --
04/24/2019 Q1 -- $1.4B $0.19 -- --
01/31/2019 Q4 -- $1.4B $0.12 -- --
10/24/2018 Q3 -- $1.3B $0.12 -- --
07/26/2018 Q2 -- $1.3B $0.12 -- --
04/24/2018 Q1 -- $1.4B $0.16 -- --
02/01/2018 Q4 -- $1.3B $0.08 -- --
10/25/2017 Q3 -- $1.2B $0.12 -- --
07/27/2017 Q2 -- $1.1B $0.10 -- --
04/25/2017 Q1 -- $1.1B $0.10 -- --
02/01/2017 Q4 -- $1.2B $0.06 -- --
10/25/2016 Q3 -- $1.1B $0.07 -- --
07/21/2016 Q2 -- $1.2B $0.10 -- --
03/31/2016 Q1 -- $1B $0.08 -- --

Chugai Pharmaceutical Co., Ltd. Earnings Questions

  • How Much did Chugai Pharmaceutical Co., Ltd. Generate in Revenue Last Quarter?

    Chugai Pharmaceutical Co., Ltd. reported $2.2B worth of top line sales in its most recent quarter.

  • Did Chugai Pharmaceutical Co., Ltd. Beat Earnings Last Quarter?

    Chugai Pharmaceutical Co., Ltd. announced earnings per share of $0.51 which represents a beat of analyst forecast a -- per share.

  • Is Chugai Pharmaceutical Co., Ltd. Profitable?

    Chugai Pharmaceutical Co., Ltd. reported $1.7B that represents $0.96 per share over the last quarter.

  • What is the Analyst Consensus for Chugai Pharmaceutical Co., Ltd. EPS Next Year?

    Chugai Pharmaceutical Co., Ltd.'s earnings are forecast to grow from $1.76 per share to -- per share next year representing an increase of --.

  • When is Chugai Pharmaceutical Co., Ltd.'s Earnings Date?

    Chugai Pharmaceutical Co., Ltd.'s next earnings date is April 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
73
ENPH alert for Feb 5

Enphase Energy, Inc. [ENPH] is up 38.57% over the past day.

Sell
2
PYPL alert for Feb 5

PayPal Holdings, Inc. [PYPL] is down 1.61% over the past day.

Sell
46
SHNY alert for Feb 5

MicroSectors Gold 3X Leveraged ETN [SHNY] is up 0.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock